Video: Knock on Wood| Webinar: ACR/CHEST ILD Guidelines in Practice
fa-facebookfa-linkedinfa-youtube-playfa-rss

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Search results for: osteoporosis

Value-Based Care Continues to Evolve in Rheumatology

Vanessa Caceres  |  April 24, 2023

Value-based care in rheumatology continues to evolve, and rheumatologists can stay active with advocacy efforts behind value-based care and other government relations initiatives.

Filed under:Practice Support Tagged with:ACR on AirACR on Air podcastcostsvalue-based care

ACR Insurance Subcommittee Tackles Known Issues

Rebecca Shepherd, MD, MBA, FACR, FACP  |  April 10, 2023

During a busy start to 2023, the ISC has been advocating with payers to address multiple coverage and reimbursement challenges facing rheumatology practices, including Cigna’s modifier 25 requirements, hydroxychloroquine access and coverage for apremilast combination therapy.

Filed under:InsuranceLegislation & Advocacy Tagged with:ACR advocacyACR Insurance Subcommittee (ISC)apremilastCigna Corp.Hydroxychloroquine (HCQ)modifier 25prior authorizationRebecca Shepherd

Tips to Alleviate Rheumatologist Burnout

Vanessa Caceres  |  April 7, 2023

Because rheumatology is a complex cognitive specialty, rheumatologists and rheumatology professionals often see patients repeatedly for acute and chronic problems. Although that may lead to close relationships with patients, it may also make the specialty more prone to burnout, says Peter Y. Hahn, MD, MBA, CEO of University of Michigan Health-West, Wyoming, Mich. “It can…

Filed under:Practice SupportProfessional TopicsWorkforce Tagged with:Advanced Practice Cliniciansburnoutnurse practitioner

Why Would You Ever Write a Letter of Recommendation or Support?

Marian T. Hannan, DSc, MPH  |  April 7, 2023

I vividly recollect asking my physics professor for a letter of recommendation. I sat in the front row of his lectures and visited his office hours most weeks in the semester. He turned me down because he was “too busy.” I was devastated—and panicked about asking my next choice for letter writer. On the plus…

Filed under:Career DevelopmentEducation & TrainingProfessional Topics Tagged with:Advocacyrecommendations

Glucocorticoid Use May Result in Loss of Bone Mineral Density

Michele B. Kaufman, PharmD, BCGP  |  March 8, 2023

Adami et al. examined the fracture risk associated with glucocorticoid treatment in women with inflammatory rheumatic musculoskeletal diseases, finding that low-dose glucocorticoid use may result in significant bone mineral density loss in patients who are not on anti-osteoporotic drugs.

Filed under:ACR ConvergenceDrug Updates Tagged with:ACR Convergence 2022bone lossbone mineral density (BMD)fracture riskGlucocorticoidsinflammatory musculoskeletal disease

The ACR Selects Tien-I Karleen Su, MD, FACR, as Community Practice Council Chair

Joseph Cantrell, JD  |  March 3, 2023

Tien-I Karleen Su, MD, FACR, who co-founded a practice in California, has been named the first chair of the CPC. Her first task will be to help fill out the council with rheumatology professionals from small or independent practices.

Filed under:Legislation & AdvocacyProfessional Topics Tagged with:Community Practice CouncilVolunteering

Supplemental Vitamin D May Not Protect Against Fractures in Healthy Adults

Lara C. Pullen, PhD  |  March 2, 2023

Supplemental vitamin D may not significantly lower the risk of fractures in generally healthy adults compared with placebo, according to a large study by LeBoff et al.

Filed under:Conditions Tagged with:fracture riskFracturesVitamin Dvitamin D supplementationVitamin D3

Lost and found

A Look Back at the First Use of Cortisone in Rheumatoid Arthritis

Ruth Jessen Hickman, MD  |  January 17, 2023

In 1949, the first description of patients with rheumatoid arthritis (RA) given cortisone sent shockwaves through the medical community, quickly capturing the public imagination as well. The paradigm-shifting report paved the way for the use of cortisone and related drugs in RA and many other medical conditions.1 The following is a discussion of some of…

Filed under:ConditionsRheumatoid Arthritis Tagged with:cortisoneLost & Found

Patients on Dialysis Taking Denosumab May Be at Risk of Severe Hypocalcemia

Michele B. Kaufman, PharmD, BCGP  |  December 12, 2022

The FDA is investigating the risk of severe hypocalcemia with serious outcomes, such as hospitalization and death, in patients on dialysis taking denosumab.

Filed under:Drug Updates Tagged with:denosumabdialysisDrug SafetyFDAhypocalcemiaRenal diseaseU.S. Food and Drug Administration (FDA)

The 2022 ACR Masters

Patrice Fusillo  |  December 8, 2022

Recognition as an ACR Master is one of the highest honors the College bestows. The designation of Master is conferred on ACR members, age 65 or older by Oct. 1 of the year in which they are nominated, who have made outstanding contributions to the ACR and the field of rheumatology through scholarly achievement and/or…

Filed under:AwardsProfessional Topics Tagged with:Dr. Abraham “Avi” GedaliaDr. Alan KivitzDr. Andrew LasterDr. Anne DavidsonDr. Arvind ChopraDr. Asgar Ali KallaDr. Carlos D. RoseDr. Daniel AlbertDr. David A. CabralDr. Deh-Ming ChangDr. Ellen M. GravalleseDr. Frederick B. VivinoDr. H. Michael BelmontDr. Ken SchiklerDr. Larry W. MorelandDr. Leslie E. KahlDr. Linda BockenstedtDr. Maria C. CidDr. Max HamburgerDr. Munther A. KhamashtaDr. Nancy J. OlsenDr. Nina D. SchwartzDr. Richard BucalaDr. Robert A. S. RoubeyDr. Robert H. ShmerlingDr. Robert W. WarrenDr. Samina Hayat

  • « Previous Page
  • 1
  • …
  • 10
  • 11
  • 12
  • 13
  • 14
  • …
  • 58
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
fa-facebookfa-linkedinfa-youtube-playfa-rss
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences